Journal of Critical and Intensive Care 2020 , Vol 11 (Supplement)
Chloroquine and Hydroxychloroquine in Treatment of COVID-19 Disease
Fatma YILDIRIM 1
1University of Health Sciences, Diskapi Yıldırım Beyazıt Research and Education Hospital, General Surgery and Medical Intensive Care Units, Ankara, Turke DOI : 10.37678/dcybd.2020.2387 The use of chloroquine and its derivatives as an anti-viral agent is supported by pre-clinical in-vitro studies and its clinical safety is known in the term of its other indications. But there is insufficient clinical data to support its use in critically ill patients with The noval corona virus disease 2019 (COVID-19). Nevertheless, it is recommended that these drugs, which are supported by the urgency of the COVID-19 pandemic in many national guidelines and consensus reports, including our country, should be applied in accordance with the guidelines. Keywords : Chloroquine, Hydroxychloroquine, Suggestion, Corona-19